Evidence map›Paper›PMID 25702087›Full record

ReviewVirology2015

Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.

Thomas M Kristie

Open access · greenAbstract readReview
In one paragraph

Review in Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas M KristieMolecular Genetics Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bld 33, Rm 3W20B.7 33 North Drive,, Bethesda, MA 20892, USA. Electronic address: tkristie@niaid.nih.gov.
National Institute of Allergy and Infectious Diseases · US

Funding

Transcriptional control of herpes simplex virus lytic infection and latency-reactivation cyclesZIAAI000712 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KRISTIE, THOMAS M · 2009 to 2025
$13.0M
HCF-1, A Mammalian Factor Controlling HSV Gene ExpressionZIAAI000711 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KRISTIE, THOMAS M · 2009 to 2017
$5.4M
NOVEL MAMMALIAN TRANSCRIPTION FACTOR INVOLVED IN HSV GENE EXPRESSIONZ01AI000711 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KRISTIE, THOMAS M · 1994 to 2008
$1.3M
Regulation Of Transcription Of Herpes Simplex VirusZ01AI000712 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KRISTIE, THOMAS M · 1994 to 2008
$847k
Intramural NIH HHS Z01 AI000711Intramural NIH HHS Z01 AI000712
6 · The paper itself

Abstract

Upon infection, the genomes of herpesviruses undergo a striking transition from a non-nucleosomal structure to a chromatin structure. The rapid assembly and modulation of nucleosomes during the initial stage of infection results in an overlay of complex regulation that requires interactions of a plethora of chromatin modulation components. For herpes simplex virus, the initial chromatin dynamic is dependent on viral and host cell transcription factors and coactivators that mediate the balance between heterochromatic suppression of the viral genome and the euchromatin transition that allows and promotes the expression of viral immediate early genes. Strikingly similar to lytic infection, in sensory neurons this dynamic transition between heterochromatin and euchromatin governs the establishment, maintenance, and reactivation from the latent state. Chromatin dynamics in both the lytic infection and latency-reactivation cycles provides opportunities to shift the balance using small molecule epigenetic modulators to suppress viral infection, shedding, and reactivation from latency.

Indexed as

Epigenesis, GeneticGene Expression Regulation, ViralVirus LatencyVirus ReplicationChromatinHost-Pathogen InteractionsSimplexvirusTranscription FactorsChromatinTranscription FactorsChromatinDemethylaseHCF-1Herpes simplex virusJMJD2LatencyLSD1

Identifiers

PMID25702087
PMCPMC4424070
OpenAlexW2003835295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.